These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7913159)

  • 1. p53 and behaviour of colorectal cancer.
    Goh HS; Chan CS; Khine K; Smith DR
    Lancet; 1994 Jul; 344(8917):233-4. PubMed ID: 7913159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mutations and DNA ploidy in colorectal adenocarcinomas.
    Campomenosi P; Assereto P; Bogliolo M; Fronza G; Abbondandolo A; Capasso A; Bellomo PF; Monaco R; Rapallo A; Sciutto A; Orecchia R; Geido E; Giaretti W
    Anal Cell Pathol; 1998; 17(1):1-12. PubMed ID: 9807634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of p53 expression and DNA ploidy pattern in colorectal cancer].
    Nakamura T; Hishiki S; Baba S
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):780-3. PubMed ID: 8489286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic diagnosis of lymph-node metastasis in colorectal cancer.
    Hayashi N; Ito I; Yanagisawa A; Kato Y; Nakamori S; Imaoka S; Watanabe H; Ogawa M; Nakamura Y
    Lancet; 1995 May; 345(8960):1257-9. PubMed ID: 7746054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
    Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
    Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH.
    Forslund A; Kressner U; Lönnroth C; Andersson M; Lindmark G; Lundholm K
    Int J Oncol; 2002 Aug; 21(2):409-15. PubMed ID: 12118339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A detailed study of p53 mutations in colorectal cancer in Singapore.
    Smith DR; Chan CS; Goh HS
    Ann Acad Med Singap; 1994 Nov; 23(6):803-9. PubMed ID: 7741489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Flow cytometric measurement of p53 protein and DNA content in colorectal carcinomas with liver metastasis].
    Kimura O; Hisamitsu K; Sugamura K; Nakamura S; Kurayoshi K; Makino M; Kaibara N
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():134-9. PubMed ID: 7611776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 point mutation and survival in colorectal cancer patients: effect of disease dissemination and tumour location.
    Goh HS; Elnatan J; Low CH; Smith DR
    Int J Oncol; 1999 Sep; 15(3):491-8. PubMed ID: 10427130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 as an indicator of lymph node metastases in invasive early colorectal cancer.
    Makino M; Yamane N; Taniguchi T; Honboh T; Kurayoshi K; Kaibara N
    Anticancer Res; 2000; 20(3B):2055-9. PubMed ID: 10928151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma.
    Slebos RJ; Baas IO; Clement M; Polak M; Mulder JW; van den Berg FM; Hamilton SR; Offerhaus GJ
    Br J Cancer; 1996 Jul; 74(2):165-71. PubMed ID: 8688317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The expression of mutation p53 gene from circulating cancer cells of peripheral blood and the clinical significance in detecting the patients with colorectal cancer].
    Ma GJ; Zhou JN; Shen ZL; Chen SQ; Zhu YQ; Wu XL; Xue KX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):186-8. PubMed ID: 16604493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of cellular heterogeneity by DNA ploidy, 17 chromosome, and p53 gene in primary carcinoma and metastasis in a case of ovarian cancer.
    Calugi A; Eleuteri P; Cavallo D; Naso G; Albonici L; Lombardi MP; Manzari V; Romanini C; DeVita R
    Int J Gynecol Pathol; 1996 Jan; 15(1):77-81. PubMed ID: 8852451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
    Ahnen DJ; Feigl P; Quan G; Fenoglio-Preiser C; Lovato LC; Bunn PA; Stemmerman G; Wells JD; Macdonald JS; Meyskens FL
    Cancer Res; 1998 Mar; 58(6):1149-58. PubMed ID: 9515799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer.
    Kaserer K; Schmaus J; Bethge U; Migschitz B; Fasching S; Walch A; Herbst F; Teleky B; Wrba F
    J Pathol; 2000 Mar; 190(4):450-6. PubMed ID: 10699994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 gene expression in node-positive breast cancer: relationship to DNA ploidy and prognosis.
    Cunningham JM; Ingle JN; Jung SH; Cha SS; Wold LE; Farr G; Witzig TE; Krook JE; Wieand HS; Kovach JS
    J Natl Cancer Inst; 1994 Dec; 86(24):1871-3. PubMed ID: 7990162
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
    Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K
    J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up.
    Russo A; Migliavacca M; Zanna I; Valerio MR; Latteri MA; Grassi N; Pantuso G; Salerno S; Dardanoni G; Albanese I; La Farina M; Tomasino RM; Gebbia N; Bazan V
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1322-31. PubMed ID: 12433709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on relationship between intratumoral DNA heterogeneity and clinicopathological findings in colorectal cancer].
    Funahashi K; Tsujita K; Miki T; Koike J; Takatsuki M; Kubota S; Watanabe M; Yanagita K; Yoshio T
    Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():47-51. PubMed ID: 8203930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.